Alzheimer’s disease – current trends in basic and clinical research. Highlights from the 16th ECNP

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.1, 2004-01, pp. : 79-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Commentary: Research Highlights: IKK&bgr; Mediates A&bgr;-Triggered Microglial Inflammation and Neuronal Death During Alzheimer's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-01 ,pp. : 1305-1307

Bentham Science Publishers

Access to resources Recommend Favorite

Commentary: Research Highlights ATF4: The Perpetrator in Axonal-Mediated Neurodegeneration in Alzheimer's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 9, 2014-11 ,pp. : 1483-1484

Bentham Science Publishers

Access to resources Recommend Favorite

Conference Report: 10th Clinical Trials on Alzheimer's Disease (CTAD), Boston MA, USA, November 1-4, 2017

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 10, 2018-03 ,pp. : 1134-1137

Bentham Science Publishers

Access to resources Recommend Favorite

6th International Conference on Alzheimer’s Disease and Parkinson’s Disease

By Lahiri Debomoy K

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 8, 2003-08 ,pp. : 1433-1440

Informa Healthcare

Access to resources Recommend Favorite

Commentary ([Research Highlights] A Toll Road to Alzheimer Disease?)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 445-446

Bentham Science Publishers

Access to resources Recommend Favorite